The 2023 International Kidney Cancer Symposium: North America will feature three special awards honoring standout members of the kidney cancer community. The meeting will take place in Nashville, Tennessee from November 9-11. Register now.
We rounded up a few research highlights from the 2023 Congress of the European Society for Medical Oncology (ESMO), held recently in Madrid, Spain. Two new first-line treatment immunotherapy options Toripalimab is a new immunotherapy infusion, a…
Three analyses of the LITESPARK trial examining the hypoxia-inducible factor 2a (HIF-2a) belzutifan (Welireg) showed efficacy and benefit for this novel therapy over comparator treatments in advanced clear cell renal cell carcinoma (RCC) as well…
This is a guest post by Lindsay Walker. Lindsay, 46, was diagnosed with stage 3 chromophobe renal cell carcinoma in November 2022, right after Halloween. My kidney cancer journey began on Halloween 2022. I never…
The KCA recently partnered with two advocacy groups on a blog post examining the relationship between exercise and sickle cell trait. This blog post appears at Sick Cells, a national non-profit advocacy group for sickle…
Dr. Brendan Guercio received a 2023 Interdisciplinary RCC Focus Award for research on “Associations of diet with the gut microbiome among patients with advanced/metastatic RCC receiving immune checkpoint inhibition.” This award was supported by a…
Dr. Niki Zacharias Millward, PhD, received a 2023 KCA Chromophobe RCC Focus Award for research on “Leveraging patient-derived xenograft models to identify and therapeutically target metabolic hallmarks of chromophobe renal cell carcinoma.” Dr. Millward is…
Dr. Shinji Ohtake received a 2023 Unclassified/Papillary RCC Focus Award for research on the “Development of Models of NF2 loss in papillary and unclassified variant of kidney cancer.” This award was supported by a gift…
Dr. Prateek Khanna received a 2023 KCA Translocation RCC Focus Award for research on “Therapeutic targeting of cell surface antigens in translocation renal cell carcinoma.” This award was given in partnership with Joey’s Wings Foundation,…
Dr. Rana McKay received a 2023 KCA Trailblazer Award for research on “Dissecting predictors of response to immunotherapy in patients with renal cell carcinoma.” Dr. McKay is a medical oncologist at UC San Diego Health…